
News|Articles|March 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 3, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, March 3, 2022, at 8:00 PM, EDT:
43.9% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
According to the CDC as of today, March 3, 2022, at 8:00 PM, EDT:
• 65% of total US population
• 69.1% of US population aged ≥5 years
• 73.5% of US population aged ≥12 years
• 75% of US population aged ≥18 years
• 88.8% of US population aged ≥65 years
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 81.5%
2. Rhode Island: 80.8%
3. Vermont: 80.2%
4. Maine: 78.4%
5. Connecticut: 77.9%
2. Rhode Island: 80.8%
3. Vermont: 80.2%
4. Maine: 78.4%
5. Connecticut: 77.9%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, March 3, 2022 at 4:21 PM, EDT, there have been:
• 79 171 907 confirmed cases and
• 955 614 deaths
• 955 614 deaths
The 5 states with the highest total confirmed cases are:
1. California: 8 995 395
2. Texas: 6 630 435
3. Florida: 5 844 096
4. New York: 4 930 987
5. Illinois: 3 035 870
2. Texas: 6 630 435
3. Florida: 5 844 096
4. New York: 4 930 987
5. Illinois: 3 035 870
Deaths: California has the highest number of deaths due to COVID-19 with 85 966 reported fatalities, followed by Texas with 85 367 and Florida with 70 247.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 441 717 402 confirmed cases, 5 980 941 deaths, and 10 549 314 885 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Lilly's Novel Oral GLP-1 Orforglipron Shows Superior Efficacy in 2 Phase 3 Trials
2
"Shared Decision-Making" for COVID-19 Vaccination Signals "Optional" to Too Many, Says Kelly Moore, MD, MPH
3
Three GLP-1 Receptor Agonists Show Comparable Cardiorenal Protection in Large US Cohort with T2D
4
Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials
5